HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
SLC34A3
solute carrier family 34 member 3
Chromosome 9 Β· 9q34.3
NCBI Gene: 142680Ensembl: ENSG00000198569.10HGNC: HGNC:20305UniProt: Q8N130
29PubMed Papers
21Diseases
0Drugs
96Pathogenic Variants
FUNCTIONAL ROLE
Transporter
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
sodium:phosphate symporter activityprotein bindingsodium ion transportphosphate ion transporthereditary hypophosphatemic rickets with hypercalciurianephrolithiasisgenetic disorderurolithiasis
✦AI Summary

SLC34A3 encodes NaPi-IIc (NPT2c), a sodium-dependent phosphate cotransporter located in the brush border membrane of renal proximal tubule cells that plays a critical role in phosphate homeostasis 1. The transporter mediates active phosphate reabsorption from urine via Na+ cotransport with a 2:1 stoichiometry, functioning as part of the kidney's mechanism to control systemic phosphate balance 12. Loss-of-function mutations in SLC34A3 cause hereditary hypophosphatemic rickets with hypercalciuria (HHRH), an autosomal recessive disorder characterized by renal phosphate wasting, hypophosphatemia, elevated 1,25(OH)2 vitamin D levels, hypercalciuria, and rickets/osteomalacia 34. Both homozygous and heterozygous carriers show significantly increased risk of kidney stones and nephrocalcinosis, with 46% of biallelic carriers developing these complications compared to 6% in unaffected family members 5. Adult patients with biallelic SLC34A3 variants have a six-fold increased prevalence of chr9 kidney disease compared to the general population 4. The transporter is regulated by phosphaturic hormones including parathyroid hormone and FGF23, and represents a potential therapeutic target for hyperphosphatemia management 12.

Sources cited
1
SLC34A3 encodes NaPi-IIc transporter in brush border membrane and its role in phosphate homeostasis
PMID: 40357590
2
Molecular mechanisms of phosphate transport and regulation by hormones
PMID: 31168066
3
SLC34A3 mutations cause HHRH with characteristic biochemical phenotype
PMID: 24076642
4
Clinical phenotypes of SLC34A3 carriers and increased CKD risk in adults
PMID: 39461557
5
Increased risk of kidney stones and nephrocalcinosis in SLC34A3 mutation carriers
PMID: 24700880
Disease Associationsβ“˜21
hereditary hypophosphatemic rickets with hypercalciuriaOpen Targets
0.81Strong
nephrolithiasisOpen Targets
0.43Moderate
genetic disorderOpen Targets
0.42Moderate
urolithiasisOpen Targets
0.37Weak
X-linked hypophosphatemiaOpen Targets
0.37Weak
hypophosphatemic nephrolithiasis/osteoporosis 1Open Targets
0.35Weak
ureterolithiasisOpen Targets
0.33Weak
HypercalciuriaOpen Targets
0.27Weak
bladder calculusOpen Targets
0.20Weak
kidney diseaseOpen Targets
0.16Weak
nephrocalcinosisOpen Targets
0.12Weak
retinitis pigmentosa 59Open Targets
0.12Weak
hypotensionOpen Targets
0.11Weak
Autosomal recessive infantile hypercalcemiaOpen Targets
0.05Suggestive
liver diseaseOpen Targets
0.05Suggestive
Idiopathic hypercalciuriaOpen Targets
0.05Suggestive
Crohn's diseaseOpen Targets
0.04Suggestive
Familial isolated hypoparathyroidismOpen Targets
0.04Suggestive
hypercalcemia, infantile, 2Open Targets
0.04Suggestive
FTH1-related iron overloadOpen Targets
0.04Suggestive
Hereditary hypophosphatemic rickets with hypercalciuriaUniProt
Pathogenic Variants96
NM_001177316.2(SLC34A3):c.575C>T (p.Ser192Leu)Pathogenic
Autosomal recessive hypophosphatemic bone disease|not provided|SLC34A3-related disorder|Hypophosphataemia or rickets
β˜…β˜…β˜†β˜†2026β†’ Residue 192
NM_001177316.2(SLC34A3):c.925+20_926-48delPathogenic
Autosomal recessive hypophosphatemic bone disease|not provided
β˜…β˜…β˜†β˜†2026
NM_001177316.2(SLC34A3):c.449-1G>CLikely pathogenic
not provided|Autosomal recessive hypophosphatemic bone disease
β˜…β˜…β˜†β˜†2026
NM_001177316.2(SLC34A3):c.1248_1249del (p.Leu417fs)Pathogenic
not provided|Autosomal recessive hypophosphatemic bone disease|SLC34A3-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 417
NM_001177316.2(SLC34A3):c.448+1G>APathogenic
not provided|Autosomal recessive hypophosphatemic bone disease
β˜…β˜…β˜†β˜†2025
NM_001177316.2(SLC34A3):c.734dup (p.Leu246fs)Pathogenic
not provided|Autosomal recessive hypophosphatemic bone disease
β˜…β˜…β˜†β˜†2025β†’ Residue 246
NM_001177316.2(SLC34A3):c.586G>A (p.Gly196Arg)Pathogenic
Autosomal recessive hypophosphatemic bone disease|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 196
NM_001177316.2(SLC34A3):c.304+2T>CPathogenic
Autosomal recessive hypophosphatemic bone disease|not provided
β˜…β˜…β˜†β˜†2025
NM_001177316.2(SLC34A3):c.1402C>T (p.Arg468Trp)Pathogenic
Autosomal recessive hypophosphatemic bone disease|not provided|SLC34A3-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 468
NM_001177316.2(SLC34A3):c.1561dup (p.Leu521fs)Pathogenic
Autosomal recessive hypophosphatemic bone disease|not provided|SLC34A3-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 521
NM_001177316.2(SLC34A3):c.1242C>A (p.Tyr414Ter)Pathogenic
Autosomal recessive hypophosphatemic bone disease|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 414
NM_001177316.2(SLC34A3):c.3G>A (p.Met1Ile)Pathogenic
not provided|Autosomal recessive hypophosphatemic bone disease|SLC34A3-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 1
NM_001177316.2(SLC34A3):c.711dup (p.Ile238fs)Pathogenic
not provided|Inborn genetic diseases
β˜…β˜…β˜†β˜†2025β†’ Residue 238
NM_001177316.2(SLC34A3):c.846+1G>ALikely pathogenic
not provided|Autosomal recessive hypophosphatemic bone disease
β˜…β˜…β˜†β˜†2025
NM_001177316.2(SLC34A3):c.1623G>A (p.Trp541Ter)Pathogenic
not provided|Autosomal recessive hypophosphatemic bone disease
β˜…β˜…β˜†β˜†2025β†’ Residue 541
NM_001177316.2(SLC34A3):c.1247del (p.Leu416fs)Pathogenic
Autosomal recessive hypophosphatemic bone disease|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 416
NM_001177316.2(SLC34A3):c.1046_1047del (p.Val349fs)Pathogenic
not provided|Autosomal recessive hypophosphatemic bone disease
β˜…β˜…β˜†β˜†2025β†’ Residue 349
NM_001177316.2(SLC34A3):c.1094-63_1115delLikely pathogenic
Autosomal recessive hypophosphatemic bone disease|not provided
β˜…β˜…β˜†β˜†2025
NM_001177316.2(SLC34A3):c.2T>C (p.Met1Thr)Pathogenic
not provided|Autosomal recessive hypophosphatemic bone disease
β˜…β˜…β˜†β˜†2025β†’ Residue 1
NM_001177316.2(SLC34A3):c.1093+2T>CPathogenic
not provided|Autosomal recessive hypophosphatemic bone disease
β˜…β˜…β˜†β˜†2025
View on ClinVar β†—
Related Genes
NHERF1Protein interaction96%ENPP1Protein interaction86%CLCN5Protein interaction84%CYP24A1Protein interaction77%CYP27B1Protein interaction77%PTHProtein interaction77%
Tissue Expression6 tissues
Bone Marrow
100%
Lung
31%
Heart
24%
Ovary
20%
Liver
9%
Brain
6%
Gene Interaction Network
Click a node to explore
SLC34A3NHERF1ENPP1CLCN5CYP24A1CYP27B1PTH
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt Q8N130
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
1.77LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF1.44 [1.17–1.77]
RankingsWhere SLC34A3 stands among ~20K protein-coding genes
  • #12,235of 20,598
    Most Researched29
  • #806of 5,498
    Most Pathogenic Variants96 Β· top quartile
  • #16,427of 17,882
    Most Constrained (LOEUF)1.77
Genes detectedSLC34A3
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Updates on renal phosphate transport.
PMID: 40357590
Curr Opin Nephrol Hypertens Β· 2025
1.00
2
Presentation and outcome in carriers of pathogenic variants in SLC34A1 and SLC34A3 encoding sodium-phosphate transporter NPT 2a and 2c.
PMID: 39461557
Kidney Int Β· 2025
0.90
3
Mutations in SLC34A3/NPT2c are associated with kidney stones and nephrocalcinosis.
PMID: 24700880
J Am Soc Nephrol Β· 2014
0.80
4
Mechanisms of phosphate transport.
PMID: 31168066
Nat Rev Nephrol Β· 2019
0.70
5
Uncovering genetic causes of hypophosphatemia.
PMID: 36999651
J Intern Med Β· 2023
0.60